| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |